Patient asking a clinician questions during a video consultation

Doko MD · Peptide

Peptide Information & Consultation

Explore the catalogue with questions about evidence, safety, and the exact formulation.

Your care starts with a conversation

Peptide catalogue

Single substances & combinations

Browse source product entries

Evidence & safety

Ask informed questions

Review risks and alternatives
  • Consultation questions
  • Product information
  • Individual goals
  • Follow-up planning
Ask About My Care

Ask about consultation availability, eligibility, and costs.

Browse Peptide products
Prepare for your consultation
Explore related product entries
Discuss your individual goals
  • Start with your questions
  • Understand your options
  • Review suitability
  • Plan your next step

Begin with your concerns

Peptide: what to discuss

Understand the exact entry

Names such as sermorelin, tesamorelin, and GHK-Cu appear alongside mixtures and nasal preparations. Evidence about one substance or approved product does not automatically apply to a different combination or route.

Separate evidence from catalogue names

The source contains names referring to recovery, cognition, and longevity. Those names are preserved for identification; they do not establish a clinical benefit or an endorsed treatment.

Check safety and regulatory status

FDA identifies potential safety concerns for several compounding substances, including BPC-157. Ask about current status, human safety data, and established alternatives before considering a peptide.

Prepare for your conversation

Write down the exact substance and formulation you are asking about, your intended goal, medical history, and current medicines. Ask whether there is an approved alternative and whether the product can legally and appropriately be supplied.

  1. Share your historyDescribe your concerns, current medicines, and previous care.
  2. Ask about assessmentConfirm service availability, any testing, and the next appropriate step.
  3. Understand the planDiscuss options, costs, monitoring, and follow-up before proceeding.

Product reference

Peptide catalogue

Explore 63 product names from the supplied pharmacy catalogue. Listed strengths and forms identify entries; they are not dosing instructions. Contact Doko MD to confirm current availability and consultation requirements.

5 Amino 1-MQ

View 1 catalogue entry
  • 50mgCapsules / eachConsultation required in source catalogue

BPC-157

View 3 catalogue entries
  • 500mcgCapsules / eachConsultation required in source catalogue
  • 3mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 4mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/KPV

View 1 catalogue entry
  • 500mcg/500mcgCapsules / eachConsultation required in source catalogue

BPC-157/KPV/PEA/Tributyrin

View 1 catalogue entry
  • 500/500mcg/400/400mgCapsules / eachConsultation required in source catalogue

Dihexa

View 2 catalogue entries
  • 10mgCapsules / eachConsultation required in source catalogue
  • 20mgCapsules / eachConsultation required in source catalogue

Epitalon

View 1 catalogue entry
  • 3mgCapsules / eachConsultation required in source catalogue

MK-677 (Ibutamoren)

View 2 catalogue entries
  • 12.5mgCapsules / eachConsultation required in source catalogue
  • 25mgCapsules / eachConsultation required in source catalogue

SLU-PP-33

View 2 catalogue entries
  • 200mcgCapsules / eachConsultation required in source catalogue
  • 1000mcgCapsules / eachConsultation required in source catalogue

GHK-Cu

View 1 catalogue entry
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Epithalon

View 1 catalogue entry
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Melanotan II (MT-2)

View 1 catalogue entry
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Melatonin II

View 1 catalogue entry
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Cerebrolysin

View 1 catalogue entry
  • 200mg/mLInjection Solution / 5 mLConsultation required in source catalogue

DSIP

View 1 catalogue entry
  • 1mg/mLInjection Solution / 5 mLConsultation required in source catalogue

TB-500

View 2 catalogue entries
  • 3mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 4mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Cardiogen

View 1 catalogue entry
  • 3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

GHRP-2

View 1 catalogue entry
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

GHRP-6

View 1 catalogue entry
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Kisspeptin

View 1 catalogue entry
  • 1mg/mLInjection Solution / 5 mLConsultation required in source catalogue

ARA-290

View 1 catalogue entry
  • 20mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Tesamorelin

View 2 catalogue entries
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 5mg/mLInjection Solution / 5 mLConsultation required in source catalogue

MOTs-C

View 2 catalogue entries
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Thymosin Alpha-1 (TA1)

View 1 catalogue entry
  • 4mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Cartalax

View 1 catalogue entry
  • 3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

SS-31

View 1 catalogue entry
  • 60mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157 & TB-500 Nasal Spray

View 1 catalogue entry
  • 10mg/10mg/mLNasal Spray / 10mLConsultation required in source catalogue

BPC-157 Nasal Spray

View 1 catalogue entry
  • 10mg/mLNasal Spray / 10mLConsultation required in source catalogue

Pinealon Nasal Spray

View 1 catalogue entry
  • 4mg/mLNasal Spray / 10mLConsultation required in source catalogue

Selank Nasal Spray

View 1 catalogue entry
  • 7.5mg/mLNasal Spray / 10mLConsultation required in source catalogue

Semax Nasal Spray

View 1 catalogue entry
  • 7.5mg/mLNasal Spray / 10mLConsultation required in source catalogue

AOD-9604

View 3 catalogue entries
  • 1.2mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 2.4mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 300mcgTroches / eachConsultation required in source catalogue

Sermorelin

View 1 catalogue entry
  • 3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

IGF-LR3

View 1 catalogue entry
  • 200mcg/mLInjection Solution / 5 mLConsultation required in source catalogue

LL-37

View 1 catalogue entry
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Semax/Selank Nasal Spray

View 1 catalogue entry
  • 10mg/10mg/mLNasal Spray / 10mLConsultation required in source catalogue

Synapsin : Rg3/NR

View 1 catalogue entry
  • RG3 2mg/B12 2mg/NR 50mg/mLNasal Spray / 10mLConsultation required in source catalogue

BPC-157/Humanin/SS-31

View 1 catalogue entry
  • 1000mcg/4mg/4mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB-500 - Wolverine Stack

View 1 catalogue entry
  • 3mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB-500/KPV/GHK-Cu - Advanced Wolverine Stack

View 1 catalogue entry
  • 3mg/3mg/3mg/10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB500

View 1 catalogue entry
  • 3mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB500/KPV

View 1 catalogue entry
  • 3mg/3mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB500/KPV - Wolverine Inflammation Control Stack

View 1 catalogue entry
  • 3mg/3mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BPC-157/TB500/KPV/GHK-U

View 1 catalogue entry
  • 3mg/3mg/3mg/10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

CJC-1295/Ipamorelin

View 2 catalogue entries
  • 1.2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 2mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

CJC-1295/Ipamorelin - Growth Hormone Optimization Stack

View 2 catalogue entries
  • 1.2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue
  • 2mg/3mg/mLInjection Solution / 5 mLConsultation required in source catalogue

DSIP/BPC-157/CJC-1295 -Night Repair Stack

View 1 catalogue entry
  • 1mg/2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

DSIP/BPC/CJC

View 1 catalogue entry
  • 1mg/2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Epitalon/Thymalin/GHK-Cu

View 1 catalogue entry
  • 20mg/10mg/4mg/mLInjection Solution / 5 mLConsultation required in source catalogue

GHK-Cu/Epithalon - Longevity & Regeneration Stack

View 1 catalogue entry
  • 10mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

LL-37/Thymosin

View 1 catalogue entry
  • 2mg/5mg/mLInjection Solution / 5 mLConsultation required in source catalogue

LL-37/Thymosin Alpha-1 - Immune Defense Stack

View 1 catalogue entry
  • 2mg/5mg/mLInjection Solution / 5 mLConsultation required in source catalogue

PE-22-28/Pinealon/Selank

View 1 catalogue entry
  • 2mg/2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

PE-22-28/Pinealon/Selank - Neurogenesis Stack

View 1 catalogue entry
  • 2mg/2mg/2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Semax/Selank

View 1 catalogue entry
  • 1mg/1mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Semax/Selank - Cognitive Enhancement Stack

View 1 catalogue entry
  • 1mg/1mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Semax/Selank/Dihexa

View 1 catalogue entry
  • 1200mcg/1000mcg/10mg/mLInjection Solution / 5 mLConsultation required in source catalogue

SLU-PP-32

View 1 catalogue entry
  • 5mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Tesamorelin/CJC-1295 (No DAC)/GHRP-6

View 1 catalogue entry
  • 2mg/600mcg/400mcg/mLInjection Solution / 5 mLConsultation required in source catalogue

Tesamorelin/Ipamorelin

View 1 catalogue entry
  • 5mg/1.5mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Thymosin Alpha-1/LL-37/BPC-157

View 1 catalogue entry
  • 3.2mg/2mg/1000mcg/mLInjection Solution / 5 mLConsultation required in source catalogue

Adamax

View 1 catalogue entry
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

BAM15

View 1 catalogue entry
  • 15mgCapsules / eachConsultation required in source catalogue

FOXO4

View 1 catalogue entry
  • 2mg/mLInjection Solution / 5 mLConsultation required in source catalogue

Your questions, answered

Are all peptides in this catalogue FDA-approved?

No. Inclusion in a pharmacy catalogue does not establish FDA approval. Compounded drugs are not FDA-approved, and approval of a particular medicine does not extend to every mixture or formulation.

Does this page promise injury recovery or anti-aging benefits?

No. The entries identify source products, including investigational substances. They do not establish safety, efficacy, eligibility, or current availability.

Is a catalogue listing a prescription?

No. This page is a product reference and general consultation guide. It does not provide diagnosis, prescribing advice, or a guarantee of treatment.

Explore other therapy areas

Ready to ask about your next step?

Contact Doko MD about consultation availability, eligibility, and costs for your area of interest.

Contact Doko MD

Catalogue source: supplied pharmacy product list. Product names are retained as supplied, including spelling variants. Catalogue listings are not independently verified as current offers. General information, not individual medical advice.

Further reading: FDA: compounded drugs and their risks ยท FDA: safety concerns for compounding substances.

DELIVERY CONFIRMATIONS

Real deliveries.

See some of the completed delivery confirmations shared by Doko Medical.

Swipe or use the arrows to explore all 5 deliveries
Full carrier screenshot showing Delivered status for a shipment to Michigan, with identifying details covered
View full screenshot Personal details redacted
Delivered

Michigan

Destination state

Carrier-confirmed deliveryThe supplied tracking record shows this shipment as delivered.

Recipient details withheld

Full carrier screenshot showing Delivered status for a shipment to New York, with identifying details covered
View full screenshot Personal details redacted
Delivered

New York

Destination state

Carrier-confirmed deliveryThe supplied tracking record shows this shipment as delivered.

Recipient details withheld

Full carrier screenshot showing Delivered status for a shipment to New York, with identifying details covered
View full screenshot Personal details redacted
Delivered

New York

Destination state

Carrier-confirmed deliveryThe supplied tracking record shows this shipment as delivered.

Recipient details withheld

Full carrier screenshot showing Delivered status for a shipment to New York, with identifying details covered
View full screenshot Personal details redacted
Delivered

New York

Destination state

Carrier-confirmed deliveryThe supplied tracking record shows this shipment as delivered.

Recipient details withheld

Full carrier screenshot showing Delivered status for a shipment to Mississippi, with identifying details covered
View full screenshot Personal details redacted
Delivered

Mississippi

Destination state

Carrier-confirmed deliveryThe supplied tracking record shows this shipment as delivered.

Recipient details withheld

A snapshot of delivery records. These are selected past examples, not live tracking or a delivery-time guarantee. Delivery timing varies. Medication requires a prescription when clinically appropriate; a delivery confirmation does not establish treatment results.

Explore how our program works